figshare
Browse
Fig 7.TIF (2.12 MB)

Meta-analysis of the overall treatment-related adverse events associated with pembrolizumab.

Download (2.12 MB)
figure
posted on 2016-08-02, 17:38 authored by Zhijuan Lin, Xing Chen, Zhifeng Li, Yiming Luo, Zhihong Fang, Bing Xu, Mingzhe Han

Subgroup analysis of patients treated with different doses of pembrolizumab revealed a dose-dependent increase in adverse events.

History

Usage metrics

    PLOS ONE

    Categories

    Keywords

    HRSystematic Reviewmelanomagain insightsurvival benefitPDdeath 1CIAntibody Monotherapytumor cellsMalignant MelanomaPFSresponse rateantibody

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC